Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 4/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | TDO2 | P48775 | 1/20 | 0.40 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | VCP | P55072 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5495692 | 0.96 | NPC1 (0.44) | NPC1RAB9ACES2CES1MAOB | |
| SCHEMBL321581 | 0.83 | CES2 (0.43) | NPC1RAB9ACES2CES1MAOB | |
| SCHEMBL30817696 | 0.83 | ALDH1A1 (0.52) | NPC1RAB9ACES2CES1MAOB | |
| SCHEMBL104151 | 0.81 | TTR (0.50) | NPC1RAB9ACES2CES1MAOB | |
| SCHEMBL9215548 | 0.81 | NPC1 (0.47) | NPC1RAB9ACES2CES1MAOB | |
| SCHEMBL10555693 | 0.81 | CES2 (0.45) | NPC1RAB9ACES2CES1MAOB | |
| SCHEMBL31302316 | 0.81 | TTR (0.50) | NPC1RAB9ACES2CES1MAOB | |
| SCHEMBL192962 | 0.80 | CES2 (0.67) | NPC1RAB9ACES2CES1ALDH1A1 | |
| SCHEMBL29470947 | 0.80 | CES2 (0.67) | NPC1RAB9ACES2CES1ALDH1A1 | |
| SCHEMBL7683262 | 0.80 | MAPT (0.40) | NPC1CES2CES1ALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3540808-B1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2025-12-17 | — | — | EP | disclosed |
| CN-118480001-A | C-Kit (V559D)/PDGFR beta double-target allosteric inhibitor and preparation method, pharmaceutical composition and application thereof | 贵州省天然产物研究中心 | 2024-08-13 | — | — | CN | disclosed |
| CN-117567508-A | Bisphosphonate containing hydroxamic acid and preparation method and application thereof | 华中师范大学 | 2024-02-20 | — | — | CN | disclosed |
| EP-3697865-B1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2022-12-28 | — | — | EP | disclosed |
| US-11161836-B2 | Organic molecules for optoelectronic devices | CYNORA GMBH (DE) | 2021-11-02 | — | — | US | disclosed |
| CN-108698982-B | Fluorine atom-containing compound and use thereof | 日产化学工业株式会社 | 2021-07-16 | — | — | CN | disclosed |
| CN-111825677-A | Selective NK-3 receptor antagonist and preparation and application thereof | 明慧医药（杭州）有限公司 | 2020-10-27 | — | — | CN | disclosed |
| EP-3404017-B1 | FLUORINE ATOM-CONTAINING COMPOUND AND USE THEREOF | NISSAN CHEMICAL IND LTD (JP) | 2020-05-13 | — | — | EP | disclosed |
| US-10590287-B2 | Charge-transporting varnish and organic electroluminescent element | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2020-03-17 | — | — | US | disclosed |
| EP-3252840-B1 | VARNISH FOR FORMATION OF CHARGE-TRANSPORTING THIN FILM | NISSAN CHEMICAL CORP (JP) | 2020-03-11 | — | — | EP | disclosed |
| US-4446075-A | DIRECT BROMINATION | RIEDEL-DE HAEN AG (DE) | 1984-05-01 | — | — | US | disclosed |
| EP-0034741-B1 | PROCESS FOR THE PREPARATION OF A SUBSTITUTED BROMOFLUOROBENZENE AND 3-BROMO-4-FLUOROBENZONITRILE | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1983-12-21 | — | — | EP | disclosed |
| US-4420433-A | REACTION WITH SILICON TETRACHLORIDE OR TITANIUM TETRACHLORIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1983-12-13 | — | — | US | disclosed |
| EP-0071065-A1 | Process for the preparation of fluorine-substituted carboxylic-acid chlorides and aldehydes | BAYER AG (DE) | 1983-02-09 | — | — | EP | disclosed |
| EP-0024611-B1 | PROCESS FOR PREPARING SUBSTITUTED BENZALDEHYDES | BAYER AG (DE) | 1983-01-12 | — | — | EP | disclosed |
| EP-0049911-A2 | Process for preparing alpha-hydroxybenzylphosphonic-acid esters | BAYER AG (DE) | 1982-04-21 | — | — | EP | disclosed |
| EP-0034741-A2 | Process for the preparation of a substituted bromofluorobenzene and 3-bromo-4-fluorobenzonitrile | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1981-09-02 | — | — | EP | disclosed |
| EP-0024611-A1 | Process for preparing substituted benzaldehydes | BAYER AG (DE) | 1981-03-11 | — | — | EP | disclosed |
| US-4160862-A | ANTIINFLAMMATORY | STERLING DRUG INC. (US) | 1979-07-10 | — | — | US | disclosed |
| US-4021431-A | ANTIINFLAMMATORY AGENTS | STERLING DRUG INC. (US) | 1977-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10590287-B2 | Charge-transporting varnish and organic electroluminescent element | SLCO4C1, SLCO2A1, SLC26A3 | NPC1 297/4885RAB9A 189/4885CES2 398/4885 |
| US-11161836-B2 | Organic molecules for optoelectronic devices | OR10J3, OR51E2, OCIAD2 | NPC1 4012/4885RAB9A 3259/4885CES2 1634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.